Após o sucesso absoluto da turnê 2024/2025, o espetáculo Luluca Responde ao vivo inicia uma nova etapa em 2026, e a primeira parada será em Natal, no dia 7 de março, no Teatro Riachuelo. Prepare-se ...

Este texto foi traduzido com a ajuda de inteligência artificial e publicado originalmente em inglês. A Casa Branca recorreu a Tom Cruise, Walter White e senhores Sith num vídeo de propaganda que ...

"We have decided to drop the current court proceedings," Novo CEO Mike Doustdar told CNBC on Monday, however, reserving the right to bring it back "if needed." It comes after an agreement between Novo ...

Novo Nordisk, the pharmaceutical company behind Ozempic, has received a warning letter from the U.S. Food and Drug Administration over issues with its procedures for reporting potential side effects ...

Add Yahoo as a preferred source to see more of our stories on Google. Board certified rheumatologist Dr. Mahsa Tehrani discusses Novo Nordisk's decision to dramatically cut the U.S. list prices for ...

Amid the company’s efforts to resolve issues raised during an FDA inspection early last year, Novo Nordisk’s operating base in Plainsboro, New Jersey—already the recipient of a recent Form 483—has ...

Wegovy maker Novo Nordisk said it is teaming up with Hims & Hers Health to sell its weight-loss drugs through the telehealth company’s platform, bringing an end to a legal dispute between the two ...

March 9 (Reuters) - Hims & Hers' (HIMS.N), opens new tab shares were up over 40% on Monday, after Novo Nordisk (NOVOb.CO), opens new tab agreed to sell its blockbuster Wegovy and ‌Ozempic drugs ...

Market Catalysts host Julie Hyman takes a look at some of Monday morning's trending tickers and stories, including Hims & Hers Health (HIMS) to start selling Novo Nordisk's (NVO) GLP-1 weight-loss ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Novo Nordisk and Hims & ...

Novo Nordisk is dismissing its patent infringement lawsuit against telehealth company Hims & Hers, as the two companies have reached an agreement that will see Novo Nordisk's branded weight loss ...

Hims & Hers and Novo Nordisk have officially laid down their swords. After a longstanding public feud, the two companies have come to an agreement that will see Novo’s branded GLP-1 weight loss and ...